LYRA

$0.00

(

0.00%

)
Quote details

stock

Lyra Therapeutics Inc

NASDAQ | LYRA

6.60

USD

$0.00

(

0.00%

)

At Close (As of Sep 8, 2025)

$11.26M

Market Cap

-

P/E Ratio

-28.99

EPS

$34.00

52 Week High

$3.81

52 Week Low

HEALTHCARE

Sector

LYRA Chart

Recent Chart
Price Action

LYRA Technicals

Tags:

LYRA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1.5M
Total Revenue $1.5M
Cost Of Revenue $471K
Costof Goods And Services Sold $471K
Operating Income -$96M
Selling General And Administrative $19M
Research And Development $44M
Operating Expenses $62M
Investment Income Net -
Net Interest Income $3M
Interest Income $3M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $471K
Income Before Tax -$93M
Income Tax Expense $39K
Interest And Debt Expense -
Net Income From Continuing Operations -$93M
Comprehensive Income Net Of Tax -
Ebit -$61M
Ebitda -$60M
Net Income -$93M

Revenue & Profitability

Earnings Performance

LYRA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $66M
Total Current Assets $43M
Cash And Cash Equivalents At Carrying Value $41M
Cash And Short Term Investments $41M
Inventory -
Current Net Receivables -
Total Non Current Assets $23M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $2.4M
Other Non Current Assets -
Total Liabilities $55M
Total Current Liabilities $13M
Current Accounts Payable $1.2M
Deferred Revenue -
Current Debt -
Short Term Debt $4.1M
Total Non Current Liabilities $42M
Capital Lease Obligations $34M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $34M
Other Current Liabilities $6.9M
Other Non Current Liabilities -
Total Shareholder Equity $12M
Treasury Stock -
Retained Earnings -$405M
Common Stock $65K
Common Stock Shares Outstanding $65M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$70M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $471K
Capital Expenditures $2.3M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $80M
Cashflow From Financing $8.5M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$93M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1.5M
Total Revenue $1.5M
Cost Of Revenue $471K
Costof Goods And Services Sold $471K
Operating Income -$96M
Selling General And Administrative $19M
Research And Development $44M
Operating Expenses $62M
Investment Income Net -
Net Interest Income $3M
Interest Income $3M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $471K
Income Before Tax -$93M
Income Tax Expense $39K
Interest And Debt Expense -
Net Income From Continuing Operations -$93M
Comprehensive Income Net Of Tax -
Ebit -$61M
Ebitda -$60M
Net Income -$93M

LYRA News

LYRA Profile

Lyra Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Lyra Therapeutics, Inc., a clinical-stage therapeutic company, focuses on the development and commercialization of new integrated drug and delivery solutions for the localized treatment of patients with diseases of the ear, nose and throat. The company is headquartered in Watertown, Massachusetts.

NXTT
+2.79%
$0.15
SKYQ
+73.45%
$0.72
OCTO
+3008.96%
$45.08
CGBS
-39.47%
$0.03
GNPX
-10.37%
$0.20
XAIR
+49.77%
$3.31
NVDA
+0.77%
$168.31
SOUN
+7.22%
$15.29
QS
+21.04%
$9.49
HOOD
+15.83%
$117.28
SNAP
-1.23%
$7.22
AAL
-0.99%
$12.95
NIO
+3.69%
$6.17
SNTG
+237.12%
$6.81
IXHL
+10.83%
$0.58
TSLA
-1.26%
$346.40
TLPH
+49.12%
$0.81
ABEV
-1.34%
$2.20
TPIC
-45.91%
$0.12
NFE
-42.85%
$1.40
AXDX
-61.36%
$0.03
HOUR
+56.16%
$5.70
RAYA
-12.69%
$0.03
WBD
+1.98%
$12.35
MARA
+0.06%
$15.20
DNN
+1.27%
$2.38
KVUE
-1.02%
$18.43
SOFI
+1.40%
$25.96
TLRY
-5.88%
$1.12
BTG
+2.87%
$4.29
RIVN
-1.54%
$13.99
LYT
-16.77%
$0.09
ONDS
+7.63%
$6.06
KEY
+1.10%
$19.14
ACRV
+34.58%
$1.79
INTC
-0.04%
$24.48
HL
+12.19%
$10.11
NVVE
+16.64%
$0.26
PFE
-1.32%
$24.55
AAPL
-0.75%
$237.88
YAAS
-21.16%
$0.08
BAC
-0.62%
$49.46
PLTR
+1.95%
$156.10
LDI
+31.83%
$3.81
CPNG
+8.95%
$31.50
MBOT
+22.95%
$4.50
ILLR
+22.34%
$0.52
AVGO
+3.21%
$345.65
VHAI
0.00%
$0.00
RIOT
+1.12%
$13.44
AMD
+0.17%
$151.41
T
-2.33%
$28.90
MGIH
+42.13%
$2.25
RMBL
+60.50%
$3.21
F
-0.42%
$11.69
ITP
-1.92%
$0.20
AIRE
+16.00%
$0.47
BBD
-0.94%
$3.15
ADD
-25.47%
$0.05
RR
+17.78%
$2.98
BMNR
+4.16%
$43.79
CMG
-3.43%
$39.65
HIMS
+2.54%
$49.64
KDP
-3.56%
$27.63
SRM
+53.27%
$10.30
AMZN
+1.51%
$235.84
GRAB
+0.58%
$5.19
HBAN
+0.56%
$17.73
NCLH
-4.40%
$24.53
GOOGL
-0.31%
$234.04
WULF
+0.76%
$9.19
PLUG
-1.36%
$1.44
PCG
-3.51%
$14.56
NOK
+0.87%
$4.59
VZ
-2.38%
$43.32
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CDT
-32.44%
$0.79
ADAP
+3.65%
$0.04
WLGS
-5.57%
$0.04
CIFR
+2.65%
$7.72
PT
+17.89%
$1.12
RIG
+2.93%
$3.16
ETWO
0.00%
$3.30
JOBY
-0.22%
$13.43
INFY
+2.50%
$16.79
RGTI
+0.33%
$15.15
CRWV
+5.00%
$93.55
MRVL
+4.21%
$66.00
SATS
+19.91%
$80.63
IREN
+0.15%
$26.19
AFMD
-34.94%
$0.18
ETHD
+1.96%
$3.63
MULN
-17.38%
$0.14
BINI
-17.38%
$0.14
AGNC
-0.28%
$10.34
SBET
+4.92%
$15.67
GOOG
-0.34%
$234.16
NBIS
-2.15%
$64.06
DVLT
+5.57%
$0.32
NXTT
+2.79%
$0.15
SKYQ
+73.45%
$0.72
OCTO
+3008.96%
$45.08
CGBS
-39.47%
$0.03
GNPX
-10.37%
$0.20
XAIR
+49.77%
$3.31
NVDA
+0.77%
$168.31
SOUN
+7.22%
$15.29
QS
+21.04%
$9.49
HOOD
+15.83%
$117.28
SNAP
-1.23%
$7.22
AAL
-0.99%
$12.95
NIO
+3.69%
$6.17
SNTG
+237.12%
$6.81
IXHL
+10.83%
$0.58
TSLA
-1.26%
$346.40
TLPH
+49.12%
$0.81
ABEV
-1.34%
$2.20
TPIC
-45.91%
$0.12
NFE
-42.85%
$1.40
AXDX
-61.36%
$0.03
HOUR
+56.16%
$5.70
RAYA
-12.69%
$0.03
WBD
+1.98%
$12.35
MARA
+0.06%
$15.20
DNN
+1.27%
$2.38
KVUE
-1.02%
$18.43
SOFI
+1.40%
$25.96
TLRY
-5.88%
$1.12
BTG
+2.87%
$4.29
RIVN
-1.54%
$13.99
LYT
-16.77%
$0.09
ONDS
+7.63%
$6.06
KEY
+1.10%
$19.14
ACRV
+34.58%
$1.79
INTC
-0.04%
$24.48
HL
+12.19%
$10.11
NVVE
+16.64%
$0.26
PFE
-1.32%
$24.55
AAPL
-0.75%
$237.88
YAAS
-21.16%
$0.08
BAC
-0.62%
$49.46
PLTR
+1.95%
$156.10
LDI
+31.83%
$3.81
CPNG
+8.95%
$31.50
MBOT
+22.95%
$4.50
ILLR
+22.34%
$0.52
AVGO
+3.21%
$345.65
VHAI
0.00%
$0.00
RIOT
+1.12%
$13.44
AMD
+0.17%
$151.41
T
-2.33%
$28.90
MGIH
+42.13%
$2.25
RMBL
+60.50%
$3.21
F
-0.42%
$11.69
ITP
-1.92%
$0.20
AIRE
+16.00%
$0.47
BBD
-0.94%
$3.15
ADD
-25.47%
$0.05
RR
+17.78%
$2.98
BMNR
+4.16%
$43.79
CMG
-3.43%
$39.65
HIMS
+2.54%
$49.64
KDP
-3.56%
$27.63
SRM
+53.27%
$10.30
AMZN
+1.51%
$235.84
GRAB
+0.58%
$5.19
HBAN
+0.56%
$17.73
NCLH
-4.40%
$24.53
GOOGL
-0.31%
$234.04
WULF
+0.76%
$9.19
PLUG
-1.36%
$1.44
PCG
-3.51%
$14.56
NOK
+0.87%
$4.59
VZ
-2.38%
$43.32
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CDT
-32.44%
$0.79
ADAP
+3.65%
$0.04
WLGS
-5.57%
$0.04
CIFR
+2.65%
$7.72
PT
+17.89%
$1.12
RIG
+2.93%
$3.16
ETWO
0.00%
$3.30
JOBY
-0.22%
$13.43
INFY
+2.50%
$16.79
RGTI
+0.33%
$15.15
CRWV
+5.00%
$93.55
MRVL
+4.21%
$66.00
SATS
+19.91%
$80.63
IREN
+0.15%
$26.19
AFMD
-34.94%
$0.18
ETHD
+1.96%
$3.63
MULN
-17.38%
$0.14
BINI
-17.38%
$0.14
AGNC
-0.28%
$10.34
SBET
+4.92%
$15.67
GOOG
-0.34%
$234.16
NBIS
-2.15%
$64.06
DVLT
+5.57%
$0.32

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.